Back to search
FDAFDA · Food and drugs·Recall number Z-2350-2015

PathoDx Strep Grouping Kit, REF 62025, packaged 60 tests per kit. Latex agglutination test for identification of beta-hemolytic streptococci of Lancefield Groups A, B, C, F or G from primary culture plates.

Published August 19, 2015 · Recall initiated: June 30, 2015

Summary

FDA records medical device Class II recall Z-2350-2015, published August 19, 2015 and initiated June 30, 2015. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 1859 kits; Lot: lot 1470133, exp. date 31 Mar 2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A reagent present may produce weak or slow reactions; continued use may result in a failure to identify target species.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Inc
Distributor
Nationwide Distribution, including Puerto Rico and the country of Canada.
Lot
lot 1470133, exp. date 31 Mar 2016
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was PathoDx Strep Grouping Kit, REF 62025, packaged 60 tests per kit. Latex agglutination test for identification of beta-hemolytic streptococci of Lancefield Groups A, B, C, F or G from primary culture plates. recalled?

Yes. FDA published recall Z-2350-2015 on August 19, 2015. Reported hazard: A reagent present may produce weak or slow reactions; continued use may result in a failure to identify target species.

What should I do if I have this product?

Voluntary: Firm initiated · Letter